Krishna Vaddi, CEO: Prelude Therapeutics PRLD Buy · Filed 25/03/14

Trade details

Type: Insider buy
Amount: $36,000
Shares · price: 50,000 sh · $0.72 a share
Held after: 1,264,775 sh
Stock: Prelude Therapeutics PRLD
Person: Krishna VaddiCEO
Trade date: 25/03/13
Filed: 25/03/14
Days to filing: 1 days

First buy since 2023

Insiders buying this week: 1 insiders
Holding change: +4.1%

Prelude Therapeutics trades, last 26 weeks

What else happened in Prelude Therapeutics around then

Filed or reported within 30 days of the trade day · 25/02/11~25/04/12

Krishna Vaddi's recent trades

Krishna VaddiCEO
BuyPrelude Therapeutics
Buy
Prelude Therapeutics
PRLD
$465.8K
675,000 sh
$465.8K
Filed 25/03/27
Traded 25/03/25
Krishna VaddiCEO
BuyPrelude Therapeutics
Buy
Prelude Therapeutics
PRLD
$11K
15,000 sh
$11K
Filed 25/03/24
Traded 25/03/21
Krishna VaddiCEO
BuyPrelude Therapeutics
Buy
Prelude Therapeutics
PRLD
$3,954
5,416 sh
$3,954
Filed 25/03/24
Traded 25/03/20
Krishna VaddiCEO
BuyPrelude Therapeutics
Buy
Prelude Therapeutics
PRLD
$22.5K
29,999 sh
$22.5K
Filed 25/03/18
Traded 25/03/14
Krishna VaddiCEO
BuyPrelude Therapeutics
Buy
Prelude Therapeutics
PRLD
$6,830
9,106 sh
$6,830
Filed 25/03/18
Traded 25/03/17